Fmoc-N-amido-PEG9-acid is a high-performance ADC linker featuring a PEG9 spacer that enhances solubility and flexibility. It facilitates efficient and stable drug-antibody conjugation, making it ideal for targeted cancer therapy development.
Structure of 1191064-81-9
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Fmoc-N-amido-PEG9-acid, a versatile compound widely applied in peptide synthesis and biomedical research, presents a spectrum of pivotal functions.
Peptide Synthesis: Serving as a fundamental component in solid-phase peptide synthesis, Fmoc-N-amido-PEG9-acid plays a crucial role in constructing peptides. Acting as a spacer, it enhances the solubility and flexibility of resulting peptides, particularly those of intricate nature, utilized in therapeutic and diagnostic realms. The compound enables the efficient and dependable synthesis of complex peptides.
Drug Delivery: Embracing innovation in drug delivery systems, Fmoc-N-amido-PEG9-acid is instrumental in designing novel approaches. The incorporation of the PEG moiety elevates the solubility and stability of drug molecules, bolstering their bioavailability and circulation time within the body. This characteristic is particularly advantageous for formulating peptide and protein drugs that necessitate prolonged systemic exposure.
Surface Modification: Extending its reach to surface functionalization, Fmoc-N-amido-PEG9-acid is harnessed for modifying diverse surfaces, including nanoparticles, biomaterials, and medical devices. By tethering PEG chains to these surfaces, the compound mitigates protein adsorption and cell adhesion, thereby amplifying biocompatibility. This technique of surface modification is vital for crafting therapeutics and implants that minimize immune reactions, leading to enhanced patient outcomes and improved clinical efficacy.
Bioconjugation: Playing a pivotal role in bioconjugation strategies, Fmoc-N-amido-PEG9-acid facilitates the linkage of biomolecules like antibodies, enzymes, and nucleic acids to synthetic carriers or other biomolecules. The PEG linker ensures that the conjugated molecules retain their biological activity and functionality, thereby enabling the development of targeted therapies, diagnostic assays, and biosensors.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00982 | Fmoc-N-amido-PEG2-acetic acid | 166108-71-0 | |
BADC-01112 | Fmoc-N-amido-PEG1-acetic acid | 260367-12-2 | |
BADC-01124 | Fmoc-N-amido-PEG4-acetic acid | 437655-95-3 | |
BADC-01954 | Fmoc-N-amido-PEG6-acetic acid | 437655-96-4 | |
BADC-01135 | Fmoc-N-amido-PEG4-propionic acid | 557756-85-1 | |
BADC-01142 | Fmoc-N-amido-PEG5-acetic acid | 635287-26-2 | |
BADC-01153 | Fmoc-N-amido-PEG8-propionic acid | 756526-02-0 | |
BADC-01171 | Fmoc-N-amido-PEG3-propionic acid | 867062-95-1 | |
BADC-01175 | Fmoc-N-amido-PEG8-acetic acid | 868594-52-9 | |
BADC-01179 | Fmoc-N-amido-PEG2-propionic acid | 872679-70-4 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.